Elsevier Inc.

SHERPA: Unknown

People

  1. Lesokhin
    Lesokhin
  2. Hassoun
    Hassoun
  3. Giralt
    Giralt
  4. Landau
    Landau
  5. Mailankody
    Mailankody
  6. Chung
    Chung
  7. Shah
    Shah
  8. Korde
    Korde
  9. Hultcrantz
    Hultcrantz
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (137)
  2. Department of Medicine (137)
  3. Hematologic Malignancies, Division of (137)
  4. Myeloma (137)
  5. Hematologic Malignancies Research (97)
  6. Survivorship Research (74)
  7. Bone Marrow Transplant (67)
  8. Sloan Kettering Institute Postdocs (45)
  9. CTCR Scholars (42)
  10. Epidemiology and Biostatistics (39)
Search Within
  1. "Myeloma"
Formats
  1. Meeting Abstract (94)
  2. Journal Article (26)
  3. Review (12)
  4. Book Section (1)
  5. Conference Paper (1)
  6. Editorial (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (137)
  2. Department of Medicine (137)
  3. Hematologic Malignancies, Division of (137)
  4. Myeloma (137)
  5. Hematologic Malignancies Research (97)
  6. Survivorship Research (74)

More Groups

People
  1. Alexander Lesokhin (65)
  2. Hani Hassoun (62)
  3. Heather Landau (59)
  4. Sergio Giralt (59)
  5. Sham Mailankody (54)
  6. David Chung (51)

More People

Years
  1. 2023 (30)
  2. 2022 (19)
  3. 2021 (10)
  4. 2020 (22)
  5. 2019 (23)
  6. 2018 (5)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (77)
  2. Biology of Blood and Marrow Transplantation (29)
  3. Best Practice and Research: Clinical Haematology (9)
  4. Seminars in Oncology (7)
  5. Transplantation and Cellular Therapy (4)
  6. European Journal of Cancer (2)

More Publications

Results (137)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
    Review

    Holstein, S. A.; Howard, A.; Avigan, D.; Bhutani, M.; Cohen, A. D.; Costa, L. J.; Dhodapkar, M. V.; Gay, F.; Gormley, N.; Green, D. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Pivotal DREAMM-2 study: Single-agent belantamab mafodotin (belamaf; GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) refractory to proteasome inhibitors and immunomodulatory agents, and refractory and/or intolerant to anti-CD38 monoclonal antibodies (mAbs), including subgroups with renal impairment (RI) and high-risk (HR) cytogenetics
    Meeting Abstract

    Lonial, S.; Lee, H. C.; Badros, A.; Trudel, S.; Nooka, A. K.; Chari, A.; Abdallah, A. O.; Callander, N. S.; Sborov, D. W.; Suvannasankha, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody (mAb) - Final primary analysis
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Bladé, J.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Management of multiple myeloma during COVID-19 pandemic
    Review

    Jethava, Y. S.; Fonseca, R.; Landgren, O.
    Leukemia Research Reports (2020)

    Fulltext@MSK | Save
  • “Please keep mom alive one more day” - Clashing directives of a dying patient and her surrogate
    Journal Article

    Latcha, S.; Lineberry, C.; Lendvai, N.; Tran, C. A.; Matsoukas, K.; Scharf, A. E.; Voigt, L. P.
    Journal of Pain and Symptom Management (2020)

    Fulltext@MSK | Save
  • Vitiligo following autologous hematopoietic stem cell transplantation
    Journal Article

    Nguyen, J.; Singh, N.; Afifi, S.; Giralt, S.; Lacouture, M. E.; Busam, K. J.; Hassoun, H.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/dL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response (RR) at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save